Keyphrases
Prostate Cancer
100%
ACK1
96%
Castration-resistant Prostate Cancer
73%
Phosphorylation
71%
TNK2
69%
Androgen Receptor
69%
Clear Cell Renal Cell Carcinoma (ccRCC)
61%
Essential Pathway
61%
Transcriptomic Characterization
61%
Epigenetics
61%
Progression Markers
61%
Ultrasound-guided
61%
Endobronchial Ultrasound
61%
Tyrosine Kinase
49%
Tumor Cells
47%
Non-small Cell Lung Cancer (NSCLC)
46%
Acetylation
42%
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA)
39%
Programmed Death-ligand 1 (PD-L1)
38%
Cytomorphology
37%
Immunohistochemistry
36%
Therapeutic Vulnerabilities
33%
Conflict of Interest
30%
Plasma Cell Neoplasm
30%
Cytological Samples
30%
BerEP4
30%
Androgen Production
30%
Histone H2A
30%
Potential Conflict
30%
MOC31
30%
Urinary Bladder Mass
30%
PARP Inhibitor (PARPi)
30%
Insurance Medicine
30%
Transbronchial Aspiration
30%
Advanced Prostate Cancer
30%
Clinical Proteomic Tumor Analysis Consortium
30%
National Cancer Institute
30%
Declare
30%
Competing Interests
30%
Specific Antibodies
30%
Bladder Mass
30%
Epithelial Cell Adhesion Molecule (EpCAM)
30%
Vulnerability
30%
Cdc42
30%
Follicular Dendritic Cell Sarcoma
30%
Urinary Bladder
30%
Lung Cancer
30%
HOXB13
30%
ATP Synthase
30%
Molecular Markers
30%
Medicine and Dentistry
Diagnosis
66%
Prostate Cancer
66%
Endobronchial Ultrasonography
61%
Neoplasm
56%
Immunohistochemistry
54%
Malignant Neoplasm
41%
Cytotechnology
41%
Non Small Cell Lung Cancer
37%
Transbronchial Aspiration
37%
Tumor Cell
36%
Lung Cancer
30%
Follicular Dendritic Cell Sarcoma
30%
PARP1
30%
Homologous Recombination
30%
Clear Cell Renal Cell Carcinoma
30%
Epithelial Cell Adhesion Molecule
30%
Plasmacytoma
30%
Bladder
30%
Recombination Repair
30%
Transcriptomics
30%
Antibodies
30%
Homeostasis
30%
Histone H3
30%
Androgen Receptor
30%
Molecular Marker
30%
Proteomics
30%
Mass Spectrometry Imaging
30%
Histopathology
30%
Biopsy Technique
30%
Programmed Death 1 Ligand 1
30%
Effusion
23%
Carcinoma
23%
PARP Inhibitor
20%
Hematopoietic System Malignancy
15%
Poly ADP Ribose Polymerase
15%
Matrix-Assisted Laser Desorption-Ionization
15%
Epidermal Growth Factor Receptor
13%
Reactive Oxygen Species
13%
Anaplastic Lymphoma Kinase
13%
Programmed Death-Ligand 1
13%
Cancer
13%
Positron Emission Tomography-Computed Tomography
10%
Germinal Center
10%
Fine-Needle Aspiration
10%
Cytodiagnosis
10%
Immunophenotyping
10%
Liquid-Based Cytology
10%
Follicular Dendritic Cells
10%
Diagnostic Error
10%
Lymphocyte
10%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
73%
Epigenetics
61%
Kinase
47%
Phosphotransferase
47%
Acetylation
41%
Tyrosine Kinase
39%
Receptor Tyrosine Kinase
39%
Cancer Cell
33%
Enhancer Region
33%
Transcriptomics
30%
ATP Synthase
30%
Histone H2A
30%
Ferroxidase
30%
Ceruloplasmin
30%
Androgen Synthesis
30%
Troponin I
30%
CDC42
30%
Alpha Chain
30%
HOXB13
30%
Immune Checkpoints
30%
C-Terminus
30%
Enzyme
30%
Histone H3
30%
Homeostasis
30%
Mass Spectrometry Imaging
30%
Matrix-Assisted Laser Desorption/Ionization
30%
Enzalutamide
19%
Tumor Progression
19%
Mitophagy
18%
Non-Receptor Tyrosine Kinase
18%
Tyrosine
15%
Mitochondrion
12%
Troponin
11%
Population
11%
T Cell
11%
Carcinogenesis
10%
Mesenchymal-Epithelial Transition
10%
PBRM1
10%
BAP1
10%
Tamsulosin
10%
Proteogenomics
10%
Eosin
10%
Polysaccharide
10%
Immunocompetent Cell
10%
Clinical Trial
10%
Extracellular Matrix Proteins
10%
Scleroprotein
10%
Receptor Antagonist
6%
Microtubule-Associated Protein
6%
Macromolecule
6%